© Reuters. FILE PHOTO: Boxes containing the Moderna COVID-19 vaccine are prepared to be shipped at the McKesson distribution center in Olive Branch, Mississippi, U.S. December 20, 2020. Paul Sancya/Pool via REUTERS/File Photo
WASHINGTON (Reuters) – The price hike for Moderna (NASDAQ:) Inc COVID-19 shots is hard to justify, White House spokesperson Karine Jean-Pierre said on Thursday.
Moderna is considering pricing its vaccine at $110 to $130 per dose in the United States when it shifts from government contracting to commercial distribution, the company’s chief executive, Stephane Bancel, told the Wall Street Journal on Monday.
Be the first to comment